Spyre Therapeutics Inc. (SYRE)
NASDAQ: SYRE
· Real-Time Price · USD
15.06
-0.01 (-0.07%)
At close: May 23, 2025, 3:59 PM
15.01
-0.33%
After-hours: May 23, 2025, 04:20 PM EDT
Spyre Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2023 |
|---|---|
| License Revenue | n/a |
| License Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 11.94M | 10.77M | 10.65M | 11.51M | 12.85M | 14.07M | 8.58M | 12.06M | 5.23M | 4.59M | 6.45M | 7.2M | 8.33M | 6.8M | 6.31M | 6.31M | 6.35M | 7.02M | 5.67M | 4.69M | 4.46M | 4.34M | 4.31M | 3.82M | 3.27M | 3.51M | 3.31M | 2.93M | 2.88M | 2.32M | 3.02M | 2.36M | 2.36M | 2.05M | 2.06M | 2.45M | 1.83M | 1.62M | 1.36M | 2.12M | 847K |
| Selling, General, and Administrative Revenue Growth | +10.89% | +1.16% | -7.50% | -10.39% | -8.71% | +63.93% | -28.83% | +130.72% | +13.92% | -28.85% | -10.42% | -13.54% | +22.43% | +7.76% | -0.02% | -0.65% | -9.49% | +23.77% | +20.91% | +5.18% | +2.69% | +0.84% | +12.87% | +16.77% | -6.81% | +5.82% | +13.26% | +1.42% | +24.51% | -23.28% | +27.75% | 0.00% | +15.37% | -0.77% | -15.65% | +33.77% | +13.24% | +18.74% | -35.89% | +150.65% | n/a |
| Research and Development Revenue | 41.62M | 50.48M | 44.74M | 32.64M | 34.93M | 33.68M | 24.66M | 17.39M | 13.78M | 14.25M | 11.98M | 15.37M | 16.98M | 16.78M | 14.85M | 13.58M | 11.86M | 15.76M | 12.45M | 16.87M | 14.56M | 17.57M | 17.84M | 14.81M | 14.39M | 11.8M | 8.93M | 9.12M | 6.87M | 5.79M | 6.24M | 5.83M | 4.95M | 4.74M | 5.38M | 4.42M | 3.6M | 3.97M | 3.13M | 2.74M | 1.62M |
| Research and Development Revenue Growth | -17.55% | +12.82% | +37.10% | -6.56% | +3.70% | +36.59% | +41.84% | +26.20% | -3.33% | +18.99% | -22.09% | -9.45% | +1.17% | +12.99% | +9.38% | +14.54% | -24.76% | +26.54% | -26.19% | +15.84% | -17.10% | -1.53% | +20.48% | +2.90% | +21.96% | +32.13% | -2.12% | +32.78% | +18.63% | -7.18% | +6.92% | +17.90% | +4.39% | -11.96% | +21.83% | +22.91% | -9.33% | +26.75% | +14.36% | +68.68% | n/a |